Jaguar Health Statistics
NASDAQ: JAGXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.227-0.10 (-30.58%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Jaguar Health by the numbers
Jaguar Health has a market capitalization of $3.0 million based on 13.35M shares outstanding. With trailing EPS of $-257.15, Jaguar Health is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 93.6% below its 50-day average and 99.7% below its 200-day average.
Average daily trading volume is 2.40M shares, or about $543,902 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
JAGX valuation vs. peer median
| Metric | JAGX | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.03M | $3.15M | -4% |
| Avg. volume | 2.40M | 252.61K | +849% |
Peer median across 8 companies: SKYE, APUS, GELS, AZTR, MDCX, KPRX, NRSN, APRE.
Valuation
- Market cap
- $3.03M
- Price / sales (latest FY)
- 0.26
- EPS (TTM)
- $-257.15
- Shares outstanding
- 13.35M
Price and trading
- Previous close
- 0.327
- Open
- 0.3119
- Day range
- 0.22 – 0.3278
- 52-week range
- 0.22 – 981.75
- Beta
- —
- Volume
- 987.20K
- Average volume
- 2.40M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 16, 2026
Additional statistics
- Market Cap
- 3.03M
- Forward Pe
- -0.04
- Eps
- -257.15
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 981.75
- Week52 Low
- 0.22
- Avg Volume
- 2.40M
- Shares Outstanding
- 13.35M
- Ma50
- 3.52
- Ma200
- 90.58
- Earnings Date
- Nov 16, 2026
- Pct From52w High
- -99.98%
- Pct From52w Low
- 3.18%